Overview
- DGIM president Dagmar Führer-Sakel says research on sex-sensitive medicine remains at an early stage, with findings from male-heavy studies routinely applied to women.
- Fundamental differences in muscle mass, fat distribution and hormones influence how drugs and therapies work, yet these factors are still not consistently built into research and care.
- Sex-specific gaps persist in autoimmune disease, cancer and cardiovascular research, with heart attack symptoms differing notably between men and women.
- Clinical studies cited report women wait longer for emergency care, receive fewer pain medications, are more often labeled psychosomatic and face lower resuscitation rates.
- Federal ministers Dorothee Bär and Nina Warken have signaled new backing for women’s health research, including female crash-test dummies and a menopause-focused funding measure, while detailed plans remain to be set out.